iDNA GENOMICS PUBLIC LTD

Registered Office: 6 THEOTOKIS, 3RD FLOOR, 1055 NICOSIA, CYPRUS

Registration Number: 415277

1st March 2023

Mr. Nikos Tripatsas

Acting General Manager

Cyprus Stock Exchange

Nicosia

ANNOUNCEMENT

Topic: Issuance and allotment of corporate bonds of IDNA Genomics Public Ltd

With the present, iDNA Genomics Public Ltd (the "Company") would like to inform the investing public that,

  1. pursuant to the decisions of the Extraordinary General Meeting of the shareholders of the Company, held on the 29th of December 2023, for the issuance of up to 6.000 convertible 8,5%, unsecured, non-guaranteed,5-year bonds of nominal value €1.000 each (the
    "Bond"), and
  2. following a private placement to a limited number of persons,

the Board of Directors of the Company (the "Board") decided the issuance and allotment of 700 Bonds and total value €700.000, being the first tranche.

The Board will take all necessary actions for the listing of the Bond to the Bond Market of the Emerging Companies Market of the Cyprus Stock Exchange.

The Company may issue additional tranches of the Bond up until the 28th of December 2023, bringing the total value of the Bond to up to €6.000.000 (six million EUR).

Kind regards,

Prusec Limited Secretary

on behalf of the Board of Directors

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

iDNA Genomics Public Ltd. published this content on 01 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 March 2023 10:28:44 UTC.